Mr. Speaker, from the very beginning of this crisis, we have worked with provinces and territories to enhance testing capacity. We have given more funds and resources to Health Canada to approve the new technologies coming on the market.
Indeed, yesterday the Minister of Public Services and Procurement and the Minister of Health announced the purchase of 7.9 million rapid point of care tests from Abbott rapid diagnostics, pending Health Canada approval.
This afternoon, Health Canada authorized that Abbott ID. We can now deploy to provinces and territories, with deliveries coming in the coming weeks.